Set the Date

Daniel MacArthur gives us the lowdown from AGBT, the annual sequencing bonanza. While there's a lot of good data being presented, the overarching theme is the evolving battle between third-gen sequencing companies, he says at Genetic Future. Illumina said in a presentation early in the week that they'd be able to "routinely generate 95 Gb (that's 95 billion bases, the equivalent of 30 human genomes) of DNA sequence per run" by the end of the year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.

Dec
05
Sponsored by
Agilent

This webinar will discuss a molecular barcode-based error correction method that enables combined mutation detection and DNA copy number profiling through circulating tumor DNA sequencing.